[DPHARMA] QoQ Quarter Result on 30-Sep-2020 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
12-Nov-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Sep-2020 [#3]
Profit Trend
QoQ- -4.09%
YoY- -4.93%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 155,439 166,454 134,086 133,772 143,331 158,713 137,755 8.39%
PBT 20,197 23,176 20,471 18,568 19,391 17,727 13,939 28.07%
Tax -4,807 -5,562 -4,278 -4,441 -4,662 -4,166 -1,906 85.38%
NP 15,390 17,614 16,193 14,127 14,729 13,561 12,033 17.84%
-
NP to SH 15,390 17,614 16,193 14,127 14,729 13,561 12,033 17.84%
-
Tax Rate 23.80% 24.00% 20.90% 23.92% 24.04% 23.50% 13.67% -
Total Cost 140,049 148,840 117,893 119,645 128,602 145,152 125,722 7.46%
-
Net Worth 614,350 635,424 642,484 584,565 581,725 540,662 525,364 11.00%
Dividend
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Div 3,530 - 42,361 - 3,421 - 34,114 -77.98%
Div Payout % 22.94% - 261.60% - 23.23% - 283.51% -
Equity
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Net Worth 614,350 635,424 642,484 584,565 581,725 540,662 525,364 11.00%
NOSH 706,330 706,026 706,026 706,026 684,383 684,383 684,383 2.12%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 9.90% 10.58% 12.08% 10.56% 10.28% 8.54% 8.74% -
ROE 2.51% 2.77% 2.52% 2.42% 2.53% 2.51% 2.29% -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 22.01 23.58 18.99 19.22 20.94 23.19 20.19 5.92%
EPS 2.18 2.49 2.29 2.03 2.15 1.98 1.76 15.35%
DPS 0.50 0.00 6.00 0.00 0.50 0.00 5.00 -78.48%
NAPS 0.87 0.90 0.91 0.84 0.85 0.79 0.77 8.48%
Adjusted Per Share Value based on latest NOSH - 706,026
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 16.16 17.30 13.94 13.91 14.90 16.50 14.32 8.40%
EPS 1.60 1.83 1.68 1.47 1.53 1.41 1.25 17.90%
DPS 0.37 0.00 4.40 0.00 0.36 0.00 3.55 -77.88%
NAPS 0.6387 0.6606 0.6679 0.6077 0.6047 0.5621 0.5461 11.01%
Price Multiplier on Financial Quarter End Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 -
Price 3.03 2.75 3.38 3.16 1.62 1.39 1.42 -
P/RPS 13.77 11.66 17.80 16.44 7.74 5.99 7.03 56.61%
P/EPS 139.03 110.23 147.37 155.66 75.27 70.15 80.52 43.97%
EY 0.72 0.91 0.68 0.64 1.33 1.43 1.24 -30.42%
DY 0.17 0.00 1.78 0.00 0.31 0.00 3.52 -86.76%
P/NAPS 3.48 3.06 3.71 3.76 1.91 1.76 1.84 52.99%
Price Multiplier on Announcement Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 17/08/21 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 13/02/20 -
Price 2.49 2.93 3.42 4.04 3.15 1.72 1.64 -
P/RPS 11.31 12.43 18.01 21.02 15.04 7.42 8.12 24.74%
P/EPS 114.25 117.44 149.11 199.01 146.36 86.80 92.99 14.72%
EY 0.88 0.85 0.67 0.50 0.68 1.15 1.08 -12.77%
DY 0.20 0.00 1.75 0.00 0.16 0.00 3.05 -83.76%
P/NAPS 2.86 3.26 3.76 4.81 3.71 2.18 2.13 21.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment